Literature DB >> 512662

Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobilities of some enzymes known to be glycoproteins. 1. Clinical findings.

P K Thomas, J D Abrams, D Swallow, G Stewart.   

Abstract

A family is described with three affected brothers, two of whom were examined, born to consanguineous parent, who in early adult life began to experience ataxia, intention myoclonus, and progressive visual failure. The brothers examined had cherry red spots at the maculae and cataracts. They were of normal intelligence. The intention myoclonus responded partially to treatment with clonazepam and pheneturide, but not to 5-hydroxytryptophan in combination with carbidopa or to sodium valproate. Studies in one patient showed the excretion of large quantities of sialylated oligosaccharides in the urine. Both patients showed deficient sialidase activity in their cultured fibroblasts. Further studies on cultured skin fibroblasts revealed increased electrophoretic mobility of six glycoprotein enzymes that was returned approximately to normal by treatment with sialidase. The clinical and biochemical findings indicate that these patients are further cases of the newly described condition sialidosis type 1.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512662      PMCID: PMC490357          DOI: 10.1136/jnnp.42.10.873

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

Review 1.  Sialidosis: a review of human neuraminidase deficiency.

Authors:  J A Lowden; J S O'Brien
Journal:  Am J Hum Genet       Date:  1979-01       Impact factor: 11.025

2.  Familial juvenile neuronal storage disease. New disease or variant of juvenile lipidosis?

Authors:  Y Itoyama; I Goto; Y Kuroiwa; M Takeichi; M Kawabuchi; Y Tanaka
Journal:  Arch Neurol       Date:  1978-12

3.  The cherry-red spot--myoclonus syndrome.

Authors:  I Rapin; S Goldfischer; R Katzman; J Engel; J S O'Brien
Journal:  Ann Neurol       Date:  1978-03       Impact factor: 10.422

4.  Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies.

Authors:  D A Wenger; T J Tarby; C Wharton
Journal:  Biochem Biophys Res Commun       Date:  1978-05-30       Impact factor: 3.575

5.  Structure of nine sialyl-oligosaccharides accumulated in urine of eleven patients with three different types of sialidosis. Mucolipidosis II and two new types of mucolipidosis.

Authors:  G Strecker; M C Peers; J C Michalski; T Hondi-Assah; B Fournet; G Spik; J Montreuil; J P Farriaux; P Maroteaux; P Durand
Journal:  Eur J Biochem       Date:  1977-05-16

6.  Inheritance of the enzyme defect in a new hexosaminidase deficiency disease.

Authors:  W G Johnson; A B Chutorian
Journal:  Ann Neurol       Date:  1978-11       Impact factor: 10.422

7.  Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobility of some enzymes known to be glycoproteins. II. Enzymes studies.

Authors:  D M Swallow; L Evans; G Stewart; P K Thomas; J D Abrams
Journal:  Ann Hum Genet       Date:  1979-07       Impact factor: 1.670

8.  A new juvenile hexosaminidase deficiency disease presenting as cerebellar ataxia. Clinical and biochemical studies.

Authors:  W G Johnson; A Chutorian; A Miranda
Journal:  Neurology       Date:  1977-11       Impact factor: 9.910

9.  Sialidosis (mucolipidosis I).

Authors:  P Durand; R Gatti; S Cavalieri; C Borrone; M Tondeur; J C Michalski; G Strecker
Journal:  Helv Paediatr Acta       Date:  1977-11

10.  Electrophysiological studies in two patients with cherry red spot--myoclonus syndrome.

Authors:  J Engel; I Rapin; D R Giblin
Journal:  Epilepsia       Date:  1977-03       Impact factor: 5.864

View more
  7 in total

1.  Progressive ataxia, focal seizures, and malabsorption syndrome in a 41 year old woman.

Authors:  C J Mumford; N A Fletcher; J W Ironside; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

Review 2.  Urinary oligosaccharides in lysosomal and other metabolic disorders.

Authors:  A Federico; G Guazzi
Journal:  Ital J Neurol Sci       Date:  1982-03

Review 3.  NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Authors:  Aiza Khan; Consolato M Sergi
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

4.  Neuraminidase deficiency: case report and review of the phenotype.

Authors:  I D Young; E P Young; J Mossman; A R Fielder; J R Moore
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

5.  Urinary oligosaccharide excretion in disorders of glycolipid, glycoprotein and glycogen metabolism. A review of screening for differential diagnosis.

Authors:  A C Sewell
Journal:  Eur J Pediatr       Date:  1980-09       Impact factor: 3.183

6.  Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult.

Authors:  S Franceschetti; G Uziel; S Di Donato; L Caimi; G Avanzini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-10       Impact factor: 10.154

7.  Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis.

Authors:  Wenjun Zou; Xin Wang; Guohong Tian
Journal:  BMC Ophthalmol       Date:  2016-03-22       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.